Growth hormone normalizes renal 1,25-dihydroxyvitamin D3-24-hydroxylase gene expression but not Na+-phosphate cotransporter (Npt2) mRNA in phosphate-deprived Hyp mice

Journal of Bone and Mineral Research

Volumn 12, Issue 10, 1997, Pages 1672-1680

  Roy, Stéphane ^a   Martel, Josée ^a   Tenenhouse, Harriet S ^a  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYVITAMIN D2 24 HYDROXYLASE; BETA ACTIN; CALCITRIOL; GROWTH HORMONE; MESSENGER RNA; SODIUM DIHYDROGEN PHOSPHATE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; HYPOPHYSECTOMY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; STEADY STATE; VITAMIN D RESISTANT RICKETS;

ANIMAL FEED; ANIMALS; CALCITRIOL; CARRIER PROTEINS; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GROWTH HORMONE; HYPOPHOSPHATEMIA, FAMILIAL; HYPOPHYSECTOMY; INSULIN-LIKE GROWTH FACTOR I; KIDNEY; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, LIVER; PHOSPHATES; PHOSPHATIDYLINOSITOLS; RATS; RNA, MESSENGER; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE I; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE II; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE III; STEROID HYDROXYLASES; SYMPORTERS;

EID: 0030815646     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.1997.12.10.1672     Document Type: Article

References (51)

1. Eicher EM, Southard JL, Scriver CR, Glorieux FH 1976 Hypophosphatemia: Mouse model for human familial hypophosphatemic (vitamin D-resistant) rickets. Proc Natl Acad Sci USA 73:4667-4671.
2. Tenenhouse HS, Scriver CR 1992 X-linked hypophosphatemia: A phenotype in search of a cause. Int J Biochem 24:685-691.
3. Rasmussen H, Tenenhouse HS 1995 Mendelian hypophosphatemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The Metabolic and Molecular Basis of Inherited Disease, 7th Ed. McGraw Hill Book Co., New York, NY, U.S.A., pp. 3717-3745.
4. Meyer RA Jr, Gray RW, Meyer MH 1980 Abnormal vitamin D metabolism in the X-linked hypophosphatemic mouse. Endocrinology 107:1577-1581.
5. Tenenhouse HS, Jones G 1990 Abnormal regulation of renal vitamin D catabolism by dietary phosphate in murine X-linked hypophosphatemic rickets. J Clin Invest 85:1450-1455.
6. 3 synthesis in rat kidney in vitro. J Biol Chem 258:1152-1155.
7. 3-1-hydroxylase activity in the vitamin D and calcium deficient X-linked Hyp mouse. Endocrinology 113:816-818.
8. 3-1-hydroxylase activity in the X-linked Hyp mouse. Endocrinology 115:634-639.
9. Nesbitt T, Drezner MK, Lobaugh B 1986 Abnormal parathyroid hormone stimulation of 25-hydroxyvitamin D-1α-hydroxylase activity in the hypophosphatemic mouse: Evidence for a generalized defect of vitamin D metabolism. J Clin Invest 77:181-187.
10. Nesbitt T, Drezner MK 1990 Abnormal parathyroid hormone-related peptide stimulation of renal 25-hydroxyvitamin D-1-hydroxylase in Hyp mice: Evidence for a generalized defect of enzyme activity in the proximal convoluted tubule. Endocrinology 127:843-848.
11. Nesbitt T, Davidai GA, Drezner MK 1989 Abnormal adenosine 3′,5′-monophosphate stimulation of renal 1,25-dihydroxyvitamin D production in Hyp mice: Evidence that 25-hydroxyvitamin D-1 α-hydroxylase dysfunction results from aberrant intracellular function. Endocrinology 124:1184-1189.
12. 3 catabolism in X-linked hypophosphatemic rickets. Endocrinology 134:1761-1767.
13. 3. Endocrinology 137:2938-2946.
14. The HYP Consortium 1995 A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat Genet 11:130-136.
15. Beck L, Soumounou Y, Martel J, Krishnamurthy G, Gauthier C, Goodyer C, Tenenhouse HS 1997 Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J Clin Invest 99:1200-1209.
16. Wilson DM, Lee PD, Morris AH, Reiter EO, Gertner JM, Marcus R, Quarmby VE, Rosenfeld RG 1991 Growth hormone therapy in hypophosphatemic rickets. Am J Dis Child 145:1165-1170.
17. Saggese G, Baroncelli GI, Bertelloni S, Perri G 1995 Long-term growth hormone treatment in children with renal hypophosphatemic rickets: Effects on growth, mineral metabolism, and bone density. J Pediatr 127:395-402.
18. Patel L, Clayton PE, Brain C, Pelekouda E, Addison GM, Price DA, Mughal MZ 1996 Acute biochemical effects of growth hormone treatment compared with conventional treatment in familial hypophosphatemic rickets. Clin Endocrinol 44:687-695.
19. 2D concentrations in response to dietary phosphate deprivation in hypophysectomized rats. Calcif Tissue Int 35:100-106.
20. Wongsurawat N, Armbrecht HJ, Zenser TV, Forte LR, Davis BB 1984 Effects of hypophysectomy and growth hormone treatment on renal hydroxylation of 25-hydroxycholecalciferol in rats. J Endocrinol 101:333-338.
21. 3 synthesis by phosphate deprivation: Evidence for a role for growth hormone. Endocrinology 116:189-193.
22. Hammerman MR, Karl IE, Hruska KA 1980 Regulation of canine renal vesicle Pi transport by growth hormone and parathyroid hormone. Biochim Biophys Acta 603:322-335.
23. Caverzasio J, Faundez R, Fleisch H, Bonjour J-P 1981 Tubular adaptation to Pi restriction in hypophysectomized rats. Pflügers Arch 392:17-21.
24. Tenenhouse HS, Klugerman AH, Gurd W, Lapointe M, Tannenbaum GS 1988 Pituitary involvement in renal adaptation to phosphate deprivation. Am J Physiol 255:R373-R378.
25. Vieth R, Fraser D 1979 Kinetic behaviour of 25-hydroxyvitamin D-1-hydroxylase and -24-hydroxylase in rat kidney mitochondria. J Biol Chem 254:12455-12460.
26. 3 in murine X-linked hypophosphatemic rickets. J Clin Invest 81:461-465.
27. Bligh EG, Dyer WJ 1959 A rapid method for total lipid extraction and purification. Can J Biochem 37:911-917.
28. Gilman M 1993 Ribonuclease protection assay. In: Ausubel AU, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds.) Current Protocols in Molecular Biology. Wiley and Sons, New York, NY, U.S.A., vol. 1, unit 4.7, pp. 1-8.
29. 3 24-hydroxylase. FEES Lett 278:195-198.
30. Murphy LJ, Bell GI, Friesen HG 1987 Tissue distribution of insulin-like growth factor I and II messenger ribonucleic acid in the adult rat. Endocrinology 120:1279-1282.
31. Hartmann CM, Wagner CA, Busch AE, Markovich D, Biber J, Lang F, Murer H 1995 Transport characteristics of a murine renal Na/Pi-cotransporter. Pflügers Arch 430:830-836.
32. Goodyer CG, Branchaud CL, Lefebvre Y 1993 Effects of growth hormone (GH)-releasing factor and somatostatin on GH secretion from early to midgestation human fetal pituitaries. J Clin Endocrinol Metab 76:1259-1264.
33. Al-Hendy A, Hortelano G, Tannenbaum GS, Chang PL 1996 Growth retardation-An unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts. Hum Gene Ther 7:61-70.
34. +-phosphate cotransport in murine X-linked hypophosphatemic rickets: Molecular characterization. J Clin Invest 93:671-676.
35. +-Pi cotransporter mRNA and immunoreactive protein in X-linked Hyp mice. Am J Physiol 268:F1062-F1069.
36. 3 to calcitroic acid: Evidence for a pathway in kidney and bone involving 24-oxidation. Biochem J 262:173-180.
37. 3 through C-24 oxidation pathway. Biochemistry 28:1763-1769.
38. 3 and its physiological implications. Steroids 49:29-53.
39. Strom TM, Francis F, Lorenz B, Boeddrich A, Econs M, Lehrach H, Meitinger T 1997 Pex gene deletions in Gy and Hyp mice provide mouse models for X-linked hypophosphatemia. Hum Mol Genet 6:165-171.
40. Roques BP, Noble F, Daugé V, Fournié-Zaluski M, Beaumont A 1993 Neutral endopeptidase 24.11: Structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87-146.
41. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M 1994 ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78:473-485.
42. Emoto N, Yanagisawa M 1995 Endothelin-converting enzyme-2 is a membrane bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268.
43. Werner A, Kempson SA, Biber J, Murer H 1994 Increase of Na/Pi-cotransport encoding mRNA in response to low Pi diet in rat kidney cortex. J Biol Chem 269:6637-6639.
44. Nesbitt T, Dresner MK 1993 Insulin-like growth factor-I regulation of renal 25-hydroxyvitamin D-1-hydroxylase activity. Endocrinology 132:133-138.
45. 3 levels in rats. Endocrinology 121:504-512.
46. 3 production. J Biol Chem 270:25461-25467.
47. Jasper H, Cassinelli H 1993 Growth hormone and insulin-like growth factor I plasma levels in patients with hypophosphatemic rickets. J Pediatr Endocrinol 6:179-184.
48. Moriwake T, Abribat T, Brazcau P, Ecarot B 1995 Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: Decreased activity and abnormal modulation by dietary phosphate. J Bone Miner Res 10:1698-1704.
49. Bichell DP, Kikuchi K, Rotwein P 1992 Growth hormone rapidly activates insulin-like growth factor 1 gene transcription in vivo. Mol Endocrinol 6:1899-1908.
50. i transport in cultured kidney cells. Am J Physiol 257:F712-F717.
51. Levi M, Lotscher M, Sorribas V, Custer M, Arar M, Kaissling B, Murer H, Biber J 1994 Cellular mechanisms of acute and chronic adaptation of rat renal phosphate transporter to alterations in dietary phosphate. Am J Physiol 267:F900-F908.